MediPrint Ophthalmics Overview
- Year Founded
-
2001
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$2.52M
- Investors
-
6
MediPrint Ophthalmics General Information
Description
Developer of an eye care pharmaceutical technology designed to provide non-invasive treatment for eye conditions. The company's platform offers drug-eluting contact lenses using a proprietary printing process, continuous medication release, preservative-free formulations, and compatibility with vision correction, enabling ophthalmic care providers to administer sustained medication delivery for conditions such as glaucoma, dry eye, myopia, and post-cataract surgery care.
Contact Information
Website
www.mediprintlens.comCorporate Office
- 5310 Eastgate Mall
- San Diego, CA 92121
- United States
Corporate Office
- 5310 Eastgate Mall
- San Diego, CA 92121
- United States
MediPrint Ophthalmics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A) | 08-Mar-2022 | $2.52M | Completed | Clinical Trials - Phase 2 | ||
| 5. Seed Round | 02-Feb-2021 | Completed | Clinical Trials - Phase 2 | |||
| 4. Accelerator/Incubator | 01-Jan-2020 | Completed | Clinical Trials - Phase 2 | |||
| 3. Accelerator/Incubator | 01-Jan-2018 | Completed | Clinical Trials - Phase 2 | |||
| 2. Grant | 01-Jan-2003 | $920K | Completed | Clinical Trials - Phase 2 | ||
| 1. Angel (individual) | Completed | Startup |
MediPrint Ophthalmics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
MediPrint Ophthalmics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MediPrint Ophthalmics Patents
MediPrint Ophthalmics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026525799-A | Contact lenses containing a drug, and a method for manufacturing and using contact lenses with sustained release of a glaucoma treatment drug and a comfort enhancer. | Pending | 06-Jun-2023 | ||
| EP-4724839-A2 | Contact lenses including medicaments and methods of making and using same including slow release of glaucoma treating drugs and comfort enhancing drugs | Pending | 06-Jun-2023 | ||
| US-20260090984-A1 | Contact lenses including medicaments and methods of making and using same including slow release of glaucoma treating drugs and comfort enhancing drugs | Pending | 06-Jun-2023 | ||
| WO-2024254134-A2 | Contact lenses including medicaments and methods of making and using same including slow release of glaucoma treating drugs and comfort enhancing drugs | Inactive | 06-Jun-2023 | ||
| WO-2024254134-A3 | Contact lenses including medicaments and methods of making and using same including slow release of glaucoma treating drugs and comfort enhancing drugs | Inactive | 06-Jun-2023 | A61F9/0017 |
MediPrint Ophthalmics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MediPrint Ophthalmics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NuFund Venture Group | Angel Group | Minority | ||
| Santen Ventures | Corporate Venture Capital | Minority | ||
| TCA Venture Group | Angel Group | Minority | ||
| CONNECT (San Diego) | Accelerator/Incubator | |||
| Octane (California) | Accelerator/Incubator |
MediPrint Ophthalmics FAQs
-
When was MediPrint Ophthalmics founded?
MediPrint Ophthalmics was founded in 2001.
-
Where is MediPrint Ophthalmics headquartered?
MediPrint Ophthalmics is headquartered in San Diego, CA.
-
What is the size of MediPrint Ophthalmics?
MediPrint Ophthalmics has 9 total employees.
-
What industry is MediPrint Ophthalmics in?
MediPrint Ophthalmics’s primary industry is Drug Delivery.
-
Is MediPrint Ophthalmics a private or public company?
MediPrint Ophthalmics is a Private company.
-
What is the current valuation of MediPrint Ophthalmics?
The current valuation of MediPrint Ophthalmics is .
-
What is MediPrint Ophthalmics’s current revenue?
The current revenue for MediPrint Ophthalmics is .
-
How much funding has MediPrint Ophthalmics raised over time?
MediPrint Ophthalmics has raised $6.99M.
-
Who are MediPrint Ophthalmics’s investors?
NuFund Venture Group, Santen Ventures, TCA Venture Group, CONNECT (San Diego), and Octane (California) are 5 of 6 investors who have invested in MediPrint Ophthalmics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
